Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide
Oregon Health Sciences University, Casey
Eye Institute, Portland, Oregon, USA
Correspondence to: J T Rosenbaum, MD, Oregon Health Sciences University, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97201, USA.
Accepted for publication 14 October 1996
BACKGROUND
Optic neuropathy is a rare
manifestation of systemic lupus erythematosus (SLE). In a previous
series most patients with optic neuropathy in association with SLE had
a final visual acuity of 20/200 or less despite corticosteroid therapy.
METHODS
Three patients (five affected eyes) with
severe retrobulbar optic neuropathy in association with SLE were
treated promptly with intravenous cyclophosphamide and corticosteroids.
RESULTS
All patients recovered excellent visual acuity.
CONCLUSION
Although optic neuropathy in
association with SLE might have several different aetiologies,
intravenous cyclophosphamide should be strongly considered as a
therapeutic alternative.
© 1997 by British Journal of Ophthalmology
This article has been cited by other articles:
-
Myers, T D, Smith, J R, Wertheim, M S, Egan, R A, Shults, W T, Rosenbaum, J T
(2004). Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease. Br. J. Ophthalmol.
88: 673-680
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
